wsj.com / .wsj-com-usbusiness / Page 10

The group said it expected to close out the year in line with market expectations after third-quarter revenue per available room rose on year.

The British luxury brand said it was taking into account major shareholder Challice Limited's position that it wouldn't sell its Mulberry shares to Frasers or support the possible offer.

Europe's largest bank by market value will split off its Hong Kong and U.K. businesses as individual units.

Tele2 reported a slightly higher third-quarter net profit, helped by growth in revenue from its core telecommunications services, though revenue and underlying earnings were a touch below expectations.

The extension comes at a critical time. The company earlier this month withdrew its full-year guidance and postponed its first investor day in seven years.

The company also said Mark Parker resigned as the chairman and named James Gorman as his replacement, effective Jan. 2.

The EU approved Swedish state aid worth $139.1 million to help steelmaker SSAB decarbonize its production.

The Wegovy maker's once-daily pill to treat type 2 diabetes has shown it cuts the risk of heart attacks and strokes in patients by up to 14%, according to a new trial.

Spravato, a depression treatment derived from club drug ketamine, was looking like a dud. Its recent success now shows a path forward for psychedelic-based medicines.

Four days spent barnstorming Pennsylvania for Donald Trump highlighted support for the tech titan leading a new government efficiency effort.